Healx and Tim Guilliams News

This is selected news for Healx and Tim Guilliams, which are filed under Sectors / Healthtech and People, respectively.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
8/9/2022 England's Rare Diseases Action Plan Needs AI To Succeed
Dr. Tim Guilliams, co-founder and CEO of Healx , is an advocate for harnessing the power of AI to accelerate treatments for rare diseases. Rare diseases are largely overlooked by pharmaceutical companies and traditional drug discovery methods, despite the fact that 1 in 17 people in the UK will be ...
Forbes
4/22/2020 15 European health startups VCs think will blow up in 2020 - Business Insider
Healx founders Tim Guilliams and David Brown Healx This story is available exclusively on Business Insider Prime. Join BI Prime and start reading now. Health startups are in the spotlight as governments around the world struggle to contain the coronavirus pandemic. Investors are eyeing disruptive firms, with investment in European ...
Business Insider
10/16/2019 Healx raises $56M to launch 40 rare disease R&D programs
Healx has raised $56 million (€51 million) to launch 40 rare disease programs while taking some of its existing assets into the clinic. The ambitious target is enabled by an AI drug discovery platform that Healx thinks gives it a scalability that has more in common with tech than biotech ...
FierceBiotech
10/16/2019 Healx raises $56M Series B to use AI to find treatments for rare diseases – TechCrunch
... 400 million people worldwide (50% of these are children). Of these diseases, 95% still lack an approved treatment today,”Healx co-founder and CEO Dr. Tim Guilliams tells TechCrunch. “The traditional model of discovery and clinical development of new medicines is very expensive in terms of costs, timelines and efficacy ...
TechCrunch
10/16/2019 Healx raises $56M Series B to use AI to find treatments for rare diseases – TechCrunch
Healx raises $56M Series B to use AI to find treatments for rare diseases Steve O'Hear @sohear / 17 hours Healx , a Cambridge, U.K.-based startup using AI to help discover new treatments for rare diseases, has raised $56 million in Series B funding. Leading the round is London-base VC ...
TechCrunch
10/16/2019 Healx raises $56 million to combat rare diseases with AI | VentureBeat
October 16, 2019 12:02 AM Above: Cofounders: Healx CEO Dr. Tim Guilliams (left) with Dr. David Brown (chairman) Healx , a company using artificial intelligence (AI) to discover new drug treatments for rare diseases, has raised $56 million in a series B round of funding led by Atomico, with participation from ...
VentureBeat
10/15/2019 Healx raises $56M to launch 40 rare disease R&D programs
Oct 16, 2019 3:00am Healx will use the money to double its headcount. (Ryzhi/Getty Images) Healx has raised $56 million (€51 million) to launch 40 rare disease programs while taking some of its existing assets into the clinic. The ambitious target is enabled by an AI drug discovery platform ...
FierceBiotech
10/15/2019 Healx healthtech startup $56 million Series B pitch deck VC investors - Business Insider
Healx founders Tim Guilliams and David Brown Healx This story requires our BI Prime membership. To read the full article, simply click here to claim your deal and get access to all exclusive Business Insider PRIME content. Samantha Lee/Business Insider British artificial intelligence startup Healx has just raised a ...
Business Insider